Early tumor shrinkage versus early response as a predictor for overall survival (OS) in patients with metastatic colorectal cancer (mCRC) treated with triplet chemotherapy regimens (TCR).
Shouki Bazarbashi
No relevant relationships to disclose
Ali Husain Aljubran
No relevant relationships to disclose
Ahmad Al Zahrani
No relevant relationships to disclose
Wael Edesa
No relevant relationships to disclose
Mohamed Nabil-Ahmed
No relevant relationships to disclose
Mohammed Shoukri
No relevant relationships to disclose